David G. Standaert
David G. Standaert
Email verificata su - Home page
Citata da
Citata da
Levodopa and the progression of Parkinson's disease
Parkinson Study Group
New England Journal of Medicine 351 (24), 2498-2508, 2004
The Parkinson progression marker initiative (PPMI)
K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ...
Progress in neurobiology 95 (4), 629-635, 2011
Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trial
Parkinson Study Group, Parkinson Study Group
Jama 284 (15), 1931-1938, 2000
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
JA Obeso, M Stamelou, CG Goetz, W Poewe, AE Lang, D Weintraub, ...
Movement disorders 32 (9), 1264-1310, 2017
Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease
AW Dunah, H Jeong, A Griffin, YM Kim, DG Standaert, SM Hersch, ...
Science 296 (5576), 2238-2243, 2002
Monitoring motor fluctuations in patients with Parkinson's disease using wearable sensors
S Patel, K Lorincz, R Hughes, N Huggins, J Growdon, D Standaert, ...
IEEE transactions on information technology in biomedicine 13 (6), 864-873, 2009
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
CW Olanow, K Kieburtz, P Odin, AJ Espay, DG Standaert, HH Fernandez, ...
The Lancet Neurology 13 (2), 141-149, 2014
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
RG Holloway, I Shoulson, S Fahn, K Kieburtz, A Lang, K Marek, ...
Archives of neurology 61 (7), 1044-1053, 2004
A2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice
JF Chen, Z Huang, J Ma, JM Zhu, R Moratalla, D Standaert, ...
Journal of Neuroscience 19 (21), 9192-9200, 1999
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
GU H÷glinger, NM Melhem, DW Dickson, PMA Sleiman, LS Wang, L Klei, ...
Nature genetics 43 (7), 699-705, 2011
Molecular markers of early Parkinson's disease based on gene expression in blood
CR Scherzer, AC Eklund, LJ Morse, Z Liao, JJ Locascio, D Fefer, ...
Proceedings of the National Academy of Sciences 104 (3), 955-960, 2007
Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat
CM Testa, DG Standaert, AB Young, JB Penney
Journal of Neuroscience 14 (5), 3005-3018, 1994
Lighting up the senses: FM1-43 loading of sensory cells through nonselective ion channels
JR Meyers, RB MacDonald, A Duggan, D Lenzi, DG Standaert, JT Corwin, ...
Journal of Neuroscience 23 (10), 4054-4065, 2003
A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study
Parkinson Study Group
Archives of Neurology 62 (2), 241-248, 2005
Atriopeptins as cardiac hormones.
P Needleman, SP Adams, BR Cole, MG Currie, DM Geller, ML Michener, ...
Hypertension 7 (4), 469-482, 1985
The pathophysiological basis of dystonias
XO Breakefield, AJ Blood, Y Li, M Hallett, PI Hanson, DG Standaert
Nature Reviews Neuroscience 9 (3), 222-234, 2008
LRRK2 inhibition attenuates microglial inflammatory responses
MS Moehle, PJ Webber, T Tse, N Sukar, DG Standaert, TM DeSilva, ...
Journal of Neuroscience 32 (5), 1602-1611, 2012
Spinal and trigeminal dorsal horn projections to the parabrachial nucleus in the rat
DF Cechetto, DG Standaert, CB Saper
Journal of Comparative Neurology 240 (2), 153-160, 1985
Organization of N‐methyl‐D‐aspartate glutamate receptor gene expression in the basal ganglia of the rat
DG Standaert, CM Testa, AB Young, JB Penney Jr
Journal of Comparative Neurology 343 (1), 1-16, 1994
Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane
AW Dunah, DG Standaert
Journal of Neuroscience 21 (15), 5546-5558, 2001
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20